Proton pump inhibitors are a group of drugs that are used a lot in diseases of the stomach such as gastroesophageal reflux disease or peptic ulcers. Rabeprazole is one of the active ingredients of this group of drugs and the main active ingredient of Eurorapi. So what effect does Eurorapi have and how should patients use it?

Eosinophilic esophagitis (eosinophilic esophagitis) is a chronic, immune-mediated disease caused by food allergens, presenting with symptoms of dysfunction. esophagitis and esophagitis dominated by eosinophils.

Eosinophilic esophagitis (EoE) is a chronic, immunological or antigenic esophageal disorder that is clinically characterized by symptoms of esophageal dysfunction and histologically by invasion infiltration of eosinophils in the esophageal epithelium.

Eosinophilic esophagitis (eosinophilic esophagitis) is a chronic, immune-mediated disease caused by food allergens, presenting with symptoms of dysfunction. esophagitis and esophagitis dominated by eosinophils. Recent consensus guidelines now include proton pump inhibitor therapy as an alternative first-line treatment. This review will discuss why proton pump inhibitors are currently being used as a first-line treatment strategy.

Eosinophilic esophagitis (eosinophilic esophagitis) is a chronic, immune-mediated disease caused by food allergens, presenting with symptoms of dysfunction. esophagitis and esophagitis dominated by eosinophils.